来自MSN10 个月
TFF Pharma gains after portfolio shakeupand TFF VORI (Voriconazole Inhalation Powder) studies. Citing Phase 2 data, the company said it has decided to prioritize the former and deprioritize the latter. “We have therefore made the ...
In all cases, voriconazole was the suspected drug; however, in 5 cases, voriconazole had been administered with another drug (morphine, cytarabine, ciprofloxacin, imatinib, acetaminophen ...
Background Voriconazole is approved for treatment of invasive aspergillosis and other invasive fungal infections, but the role for therapeutic drug monitoring (TDM) is not clear. Methods We ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果